APA (7th ed.) Citation

Kudo-Saito, C., Imazeki, H., Nagashima, K., Shoji, H., Tsugaru, K., Takahashi, N., . . . Boku, N. (2025). IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-07145-3

Chicago Style (17th ed.) Citation

Kudo-Saito, Chie, et al. "IL33-ST2 Axis Is a Predictive Biomarker for Anti-PD1 Therapeutic Efficacy in Advanced Gastric Cancer." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-07145-3.

MLA (9th ed.) Citation

Kudo-Saito, Chie, et al. "IL33-ST2 Axis Is a Predictive Biomarker for Anti-PD1 Therapeutic Efficacy in Advanced Gastric Cancer." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-07145-3.